Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database.

Enrique O MartinezJulie M JornsAmanda L KongJulie KijakWen-Yao LeeChiang-Ching HuangChandler S Cortina

Published in: Annals of surgical oncology (2022)

Patients with BNET tend to present at higher clinical stages, are more frequently hormone receptor negative, and have inferior overall survival compared with patients with IDC. Further treatment strategies and studies are needed to elucidate optimal therapies to maximize patient outcomes.

Keyphrases

neuroendocrine tumors
case control
free survival
emergency department
drug induced